Form 8-K · Current report
Ross Stores 8-K, filed Aug 20, 2026
- Filed
- CIK
- 0000745732
- Accession no.
- 0000745732-26-000038
Summary
Ross Stores reported second-quarter fiscal 2026 total sales rose 13% to $6.3 billion, with comparable store sales up 10%, and earnings per share of $2.66 that included an approximate $0.60 benefit from IEEPA tariff refunds. The company raised its fiscal 2026 earnings per share guidance to $8.61 to $8.77 and increased its 2026 new store opening plan to 115 locations.
Key points
- Second-quarter net income was $851 million, or $2.66 per share, compared with $508 million, or $1.56 per share, a year earlier.
- Second-quarter operating profits were $1.1 billion, including about $253 million from IEEPA tariff refunds.
- Ross repurchased 1.4 million shares for $319 million during the quarter under a two-year $2.55 billion authorization.
- For the first six months of fiscal 2026, sales rose 17% to $12.3 billion and comparable store sales rose 13%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On August 20, 2026, the Company issued a press release regarding the Company’s financial results for its fiscal quarter ended August 1, 2026. The full text of the Company’s press release is attached hereto as Exhibit 99.1. The information furnished with this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.